Incorporated in 2009 and listed on the Singapore Stock Exchange, Biolidics Limited (“Biolidics” or “the Company” and together with its subsidiaries “the Group”) is a precision medicine medical technology company with a focus in developing a portfolio of innovative diagnostic solutions to lower healthcare costs and improve clinical outcomes.